Ignite Creation Date:
2025-12-24 @ 12:46 PM
Ignite Modification Date:
2025-12-27 @ 9:16 PM
Study NCT ID:
NCT00885261
Status:
COMPLETED
Last Update Posted:
2014-03-27
First Post:
2009-04-19
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
The Prevalence of Metabolic Syndrome in Patients Suffering From Chronic Pain
Sponsor:
Tel-Aviv Sourasky Medical Center
Organization:
Study Overview
Official Title:
The Prevalence of Metabolic Syndrome in Patients Suffering From Chronic Pain
Status:
COMPLETED
Status Verified Date:
2009-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Obesity is considered as the epidemic of the century. Central obesity is one of the metabolic syndrome's features. It has been proven that obesity can cause back pain and headaches; thus, there might be a link between chronic pain and the syndrome.
The objective of this study is to assess the prevalence of metabolic syndrome in patients suffering from chronic pain.
The objective of this study is to assess the prevalence of metabolic syndrome in patients suffering from chronic pain.
Detailed Description:
All patients will answer a questionnaire, their hip circumference will be measured, and their BMI will be calculated (weight/(height)2 ).
The patients' blood pressure will be measured. The patients will be asked to bring their blood tests (lipids and glucose).
The patients' blood pressure will be measured. The patients will be asked to bring their blood tests (lipids and glucose).
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: